Literature DB >> 7565790

Conserved intron elements repress splicing of a neuron-specific c-src exon in vitro.

R C Chan1, D L Black.   

Abstract

The neuron-specific N1 exon of the mouse c-src transcript is normally skipped in nonneuronal cells. In this study, we examined the sequence requirements for the exclusion of this exon in nonneuronal HeLa cell nuclear extracts. We found that the repression of the N1 exon is mediated by specific intron sequences that flank the N1 exon. Mutagenesis experiments identified conserved CUCUCU elements within these intron regions that are required for the repression of N1 splicing. The addition of an RNA competitor containing the upstream regulatory sequence to the HeLa extract induced splicing of the intron downstream of N1, indicating that the competitor sequence binds to splicing repressor proteins. The similarities between this mechanism for src splicing repression and the repression of other regulated exons point to a common role of exon-spanning interactions in splicing repression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565790      PMCID: PMC230889          DOI: 10.1128/MCB.15.11.6377

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Differential binding of heterogeneous nuclear ribonucleoproteins to mRNA precursors prior to spliceosome assembly in vitro.

Authors:  M Bennett; S Piñol-Roma; D Staknis; G Dreyfuss; R Reed
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

2.  Repression of estrogen-dependent stimulation of the oxytocin gene by chicken ovalbumin upstream promoter transcription factor I.

Authors:  J P Burbach; S Lopes da Silva; J J Cox; R A Adan; A J Cooney; M J Tsai; S Y Tsai
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

Review 3.  Mechanisms for selecting 5' splice sites in mammalian pre-mRNA splicing.

Authors:  D S Horowitz; A R Krainer
Journal:  Trends Genet       Date:  1994-03       Impact factor: 11.639

4.  A purine-rich exon sequence enhances alternative splicing of bovine growth hormone pre-mRNA.

Authors:  W P Dirksen; R K Hampson; Q Sun; F M Rottman
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

5.  SR proteins promote the first specific recognition of Pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex.

Authors:  D Staknis; R Reed
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

6.  Specific interactions between proteins implicated in splice site selection and regulated alternative splicing.

Authors:  J Y Wu; T Maniatis
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

7.  Binding of the Drosophila transformer and transformer-2 proteins to the regulatory elements of doublesex primary transcript for sex-specific RNA processing.

Authors:  K Inoue; K Hoshijima; I Higuchi; H Sakamoto; Y Shimura
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

8.  Sex-lethal autoregulation requires multiple cis-acting elements upstream and downstream of the male exon and appears to depend largely on controlling the use of the male exon 5' splice site.

Authors:  J I Horabin; P Schedl
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

9.  Characterization of RNA binding specificity of the Drosophila sex-lethal protein by in vitro ligand selection.

Authors:  E Sakashita; H Sakamoto
Journal:  Nucleic Acids Res       Date:  1994-10-11       Impact factor: 16.971

10.  Smooth muscle-specific switching of alpha-tropomyosin mutually exclusive exon selection by specific inhibition of the strong default exon.

Authors:  C Gooding; G C Roberts; G Moreau; B Nadal-Ginard; C W Smith
Journal:  EMBO J       Date:  1994-08-15       Impact factor: 11.598

View more
  43 in total

1.  Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.

Authors:  C F Bourgeois; M Popielarz; G Hildwein; J Stevenin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Polypyrimidine track-binding protein binding downstream of caspase-2 alternative exon 9 represses its inclusion.

Authors:  J Côté; S Dupuis; J Y Wu
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

3.  Interaction of the U1 snRNP with nonconserved intronic sequences affects 5' splice site selection.

Authors:  O Puig; A Gottschalk; P Fabrizio; B Séraphin
Journal:  Genes Dev       Date:  1999-03-01       Impact factor: 11.361

Review 4.  RNA-protein interactions that regulate pre-mRNA splicing.

Authors:  Ravinder Singh
Journal:  Gene Expr       Date:  2002

5.  Computational analysis of candidate intron regulatory elements for tissue-specific alternative pre-mRNA splicing.

Authors:  M Brudno; M S Gelfand; S Spengler; M Zorn; I Dubchak; J G Conboy
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

6.  SRp30c is a repressor of 3' splice site utilization.

Authors:  Martin J Simard; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

7.  Combinatorial control of a neuron-specific exon.

Authors:  E F Modafferi; D L Black
Journal:  RNA       Date:  1999-05       Impact factor: 4.942

Review 8.  Polypyrimidine tract binding protein antagonizes exon definition.

Authors:  E J Wagner; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

9.  Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon.

Authors:  F Del Gatto; A Plet; M C Gesnel; C Fort; R Breathnach
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

10.  Polypyrimidine tract binding protein blocks the 5' splice site-dependent assembly of U2AF and the prespliceosomal E complex.

Authors:  Shalini Sharma; Arnold M Falick; Douglas L Black
Journal:  Mol Cell       Date:  2005-08-19       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.